Atlas Trials

Single Dose Study to Compare the Pharmacodynamics of Torasemide-PR 10 mg,Torasemide-IR 10 mg and Furosemide-IR 40 mg in Patients With Compensated Heart Failure

Clinical trial NCT01549158 · TERMINATED

Trial details

NCT number
NCT01549158
Sponsor
Ferrer Internacional S.A.
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Compensated Heart Failure
Start date
2012-02-01
Primary completion
2012-10-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.